Dynamic risk stratification in burn sepsis: methodological considerations and path forward

Lou et al. recently reported that longitudinal trajectories of albumin, IL-6, and immunoglobulin G define three distinct prognostic phenotypes in burn patients with sepsis, with markedly divergent 21‑day mortality.

To critically evaluate the methodological framework of the study and propose constructive refinements to enhance clinical translatability.

While the trajectory-based phenotyping represents a significant advance, four areas warrant attention: (1) the choice of clustering markers-albumin's sensitivity to fluid shifts and the omission of cellular immune markers may limit phenotypic resolution; (2) the requirement for complete longitudinal data introduces survivorship bias that joint modeling could address; (3) time‑varying clinical interventions likely modify biomarker trajectories and should be incorporated; and (4) early prediction algorithms are needed to enable phenotype assignment within the first days of admission.

Addressing these considerations would strengthen the robustness of the proposed phenotypes and accelerate their integration into dynamic, personalized management strategies for burn sepsis.